You may also like
PHVT Disruptive Technology Could Revolutionize Heart Failure Treatment
The early clinical promise of percutaneous heart valve technology-a group of minimally invasive devices designed to treat cardiac valve dysfunction without the need for cardiopulmonary bypass-could one day play a prominent role in curbing the costs associated with treating heart failure, which is the current number-one driver of hospitalization among Medicare patients.
7 min read
Changes in the Concentrations of Mediators in Exhaled Breath Condensate during Cardiac Valve Replacement under Cardiopulmonary Bypass and Their Relations with Postoperative Acute Respiratory Distress Syndrome
EBC analysis could be used to predict the high incidence of ARDS after cardiac valve replacement under CPB.
1 min read
Current Status of High-fidelity Simulation (EP Video)
Edward Darling discusses the current status of high-fidelity simulation from the SUNY program (46:55 minutes).
1 min read